Genetic endothelial systems biology of sickle stroke risk.

Genetic differences in endothelial biology could underlie development of phenotypic heterogeneity among persons afflicted with vascular diseases. We obtained blood outgrowth endothelial cells from 20 subjects with sickle cell anemia (age, 4-19 years) shown to be either at-risk (n=11) or not-at-risk (n=9) for ischemic stroke because of, respectively, having or not having occlusive disease at the circle of Willis. Gene expression profiling identified no significant single gene differences between the 2 groups, as expected. However, analysis of Biological Systems Scores, using gene sets that were predetermined to survey each of 9 biologic systems, showed that only changes in inflammation signaling are characteristic of the at-risk subjects, as supported by multiple statistical approaches. Correspondingly, subsequent biologic testing showed significantly exaggerated RelA activation on the part of blood outgrowth endothelial cells from the at-risk subjects in response to stimulation with interleukin-1beta/tumor necrosis factoralpha. We conclude that the pathobiology of circle of Willis disease in the child with sickle cell anemia predominantly involves inflammation biology, which could reflect differences in genetically determined endothelial biology that account for differing host responses to inflammation.

[1]  Paola Sebastiani,et al.  Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia , 2005, Nature Genetics.

[2]  Jenifer L. Breshears.  Silent Cerebral Infarcts in Sickle Cell Anemia: A Risk Factor Analysis. , 2000 .

[3]  Xuan Sun,et al.  FA-1 and VLA-4 involved in human high proliferative potentialendothelial progenitor cells homing to ischemic tissue , 2006, Thrombosis and Haemostasis.

[4]  W. Kannel,et al.  Risk factor analysis. , 1984, Progress in cardiovascular diseases.

[5]  R. Adams,et al.  Sickle cell disease: The neurological complications , 2002, Annals of neurology.

[6]  M. Law.  Neurological complications. , 2009, Cancer imaging : the official publication of the International Cancer Imaging Society.

[7]  R. Hebbel,et al.  Sickle Cell Disease: Basic Principles and Clinical Practice , 1994 .

[8]  F. Aydın.  Do human intracranial arteries lack vasa vasorum? A comparative immunohistochemical study of intracranial and systemic arteries , 1998, Acta Neuropathologica.

[9]  Liming Chang,et al.  Use of blood outgrowth endothelial cells for gene therapy for hemophilia A. , 2002, Blood.

[10]  R. Adams,et al.  The use of transcranial ultrasonography to predict stroke in sickle cell disease. , 1992, The New England journal of medicine.

[11]  J. Morris,et al.  Stroke in a cohort of patients with homozygous sickle cell disease. , 1992, The Journal of pediatrics.

[12]  Scott T. Miller,et al.  Cerebrovascular accidents in sickle cell disease: rates and risk factors. , 1998, Blood.

[13]  R. Hebbel,et al.  Origins of circulating endothelial cells and endothelial outgrowth from blood. , 2000, The Journal of clinical investigation.

[14]  S. Rothman,et al.  Sickle cell anemia and central nervous system infarction: A neuropathological study , 1986, Annals of neurology.

[15]  R. Osarogiagbon,et al.  The Endothelial Biology of Sickle Cell Disease: Inflammation and a Chronic Vasculopathy , 2004, Microcirculation.

[16]  C. Pegelow,et al.  Stroke risk in siblings with sickle cell anemia. , 2003, Blood.

[17]  W. Aird,et al.  Thrombin Stimulation of the Vascular Cell Adhesion Molecule-1 Promoter in Endothelial Cells Is Mediated by Tandem Nuclear Factor-κB and GATA Motifs* , 2001, The Journal of Biological Chemistry.

[18]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[19]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  W. Klitz,et al.  Distinct HLA associations by stroke subtype in children with sickle cell anemia. , 2003, Blood.

[21]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[22]  Scott T. Miller,et al.  Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. , 1999, Pediatrics.

[23]  R. Adams,et al.  Long‐term stroke risk in children with sickle cell disease screened with transcranial doppler , 1997, Annals of neurology.

[24]  Ncbi.  National Center for Biotechnology Information , 2008 .

[25]  Jacques Bouaud,et al.  Restoring the patient therapeutic history from prescription data to enable computerized guideline-based decision support in primary care , 2004, MedInfo.

[26]  J. Lewin,et al.  Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. , 2004, Blood.

[27]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Wald.  Note on the Consistency of the Maximum Likelihood Estimate , 1949 .

[29]  A. Malik,et al.  Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion. , 1999, Journal of immunology.